Clinical Trials List
Protocol NumberGO41944
Active
2021-09-01 - 2028-12-31
Phase III
Recruiting3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- YU-HSUAN SHIH 未分科
- CHENG-HSIEN LIN 未分科
- Tsung -Chih Chen 未分科
- ZHENG-WEI ZHOU 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jin-Hou Wu 未分科
- HSUAN JEN SHIH Division of Hematology & Oncology
- 高小雯 Division of Hematology & Oncology
- 陳建誠 Division of Radiology
- 林 潔 Division of Nuclear Medicine
- Ming-Chung Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
270 participants
